FDA approves Shire's Vyvanse for binge-eating disorder

WASHINGTON (Reuters) - The U.S. Food and Drug Administration on Friday approved Shire Plc's stimulant Vyvanse to treat binge-eating disorder, the first product to be approved for the condition.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news